Matches in Wikidata for { <http://www.wikidata.org/entity/Q64640076> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q64640076 description "clinical trial" @default.
- Q64640076 description "ensayu clínicu" @default.
- Q64640076 description "klinisch onderzoek" @default.
- Q64640076 description "клінічне випробування" @default.
- Q64640076 name "A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique" @default.
- Q64640076 type Item @default.
- Q64640076 label "A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique" @default.
- Q64640076 prefLabel "A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique" @default.
- Q64640076 P1132 Q64640076-AB8FA102-FFFE-4991-BF7B-480B4C24138E @default.
- Q64640076 P1476 Q64640076-25FE3905-C09F-4234-8FEF-7ACAE639276D @default.
- Q64640076 P17 Q64640076-32EE0157-294D-43B3-97A1-3F9431AFBAED @default.
- Q64640076 P17 Q64640076-AF296635-A67A-4065-8C5D-E64F5B9DE1DF @default.
- Q64640076 P1813 Q64640076-EDFE292D-FD80-4E2A-BE68-182FB6124D6D @default.
- Q64640076 P2899 Q64640076-54CD99EF-A602-4E00-AB8A-091D820668A8 @default.
- Q64640076 P3098 Q64640076-75A57FD7-C6CE-4124-BD86-AAA205B68A44 @default.
- Q64640076 P31 Q64640076-AB719D54-4FD9-4934-ACB4-916705461470 @default.
- Q64640076 P4135 Q64640076-D70783FB-1455-420A-B00E-01EB9FE4F52D @default.
- Q64640076 P580 Q64640076-839BD09A-0355-4DC0-BD1B-AC059C156ED1 @default.
- Q64640076 P582 Q64640076-A22FBE41-53AC-431D-B42E-C06DE03B9538 @default.
- Q64640076 P6099 Q64640076-F993098D-B334-462F-832F-16096CB4A494 @default.
- Q64640076 P6153 Q64640076-A8749320-D386-4C83-A3D1-4A605B2BDD76 @default.
- Q64640076 P767 Q64640076-6395D9CE-CB6A-43CD-AD14-8F5CA051368E @default.
- Q64640076 P8363 Q64640076-97C05EF1-5D01-418E-8226-895DCA8F847F @default.
- Q64640076 P1132 "+198" @default.
- Q64640076 P1476 "A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique" @default.
- Q64640076 P17 Q1029 @default.
- Q64640076 P17 Q924 @default.
- Q64640076 P1813 "TaMoVac II" @default.
- Q64640076 P2899 "+18" @default.
- Q64640076 P3098 "NCT01697007" @default.
- Q64640076 P31 Q30612 @default.
- Q64640076 P4135 "+40" @default.
- Q64640076 P580 "2012-11-01T00:00:00Z" @default.
- Q64640076 P582 "2014-12-01T00:00:00Z" @default.
- Q64640076 P6099 Q42824440 @default.
- Q64640076 P6153 Q6933030 @default.
- Q64640076 P767 Q189022 @default.
- Q64640076 P8363 Q78089383 @default.